Your browser doesn't support javascript.
loading
Enabling the evaluation of COVID-19 vaccines with correlates of protection.
Marchant, Arnaud; Van Damme, Pierre; Plotkin, Stanley; Neels, Pieter; Cassetti, Maria Cristina; Cramer, Jakob; Gruber, Marion F; Goldblatt, David; King, Deborah; Hartig-Merkel, Wendy; Vandeputte, Joris.
Affiliation
  • Marchant A; Institute for Medical Immunology (IMI), European Plotkin Institute for Vaccinology (EPIV), Université libre de Bruxelles, 808 Route de Lennik, 1070, Brussels, Belgium. Electronic address: arnaud.marchant@ulb.be.
  • Van Damme P; Centre for the Evaluation of Vaccination, European Plotkin Institute for Vaccinology (EPIV), Vaccine & Infectious Disease Institute, University of Antwerp, Faculty of Medicine & Health Sciences, Vaccinopolis/University of Antwerp, Drie Eikenstraat 663, 2650, Edegem, Belgium. Electronic addre
  • Plotkin S; University of Pennsylvania, 18902, Doylestown, Pennsylvania, United States. Electronic address: stanley.plotkin@vaxconsult.com.
  • Neels P; International Alliance for Biological Standardization (IABS), Rue Mina-Audemars 3, 1204, Genève, Switzerland. Electronic address: pieter.neels@vaccine-advice.be.
  • Cassetti MC; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Health (NIH), 20852, United States. Electronic address: ccassetti@niaid.nih.gov.
  • Cramer J; Coalition for Epidemic Preparedness Innovations (CEPI), Gibbs Building, 215 Euston Rd, Bloomsbury, London, NW1 2BE, United Kingdom. Electronic address: jakob.cramer@cepi.net.
  • Gruber MF; International AIDS Vaccine Initiative (IAVI), 125 Broad Street, New York, NY, 10004, United States. Electronic address: MGruber@iavi.org.
  • Goldblatt D; Infection, Immunity, and Inflammation Department, Great Ormond Street Institute of Child Health, University College London and Great Ormond Street Children's Hospital, NHS Foundation Trust, 30 Guilford Street, London, WC1N 1EH, United Kingdom. Electronic address: d.goldblatt@ucl.ac.uk.
  • King D; Wellcome Trust, Gibbs Building, 215 Euston Road, Bloomsbury, London, NW1 2BE, United Kingdom. Electronic address: D.King@wellcome.org.
  • Hartig-Merkel W; P95 Epidemiology & Pharmacovigilance, Koning Leopold III Laan 1, 3001, Leuven, Belgium. Electronic address: wendy.hartig-merkel@p-95.com.
  • Vandeputte J; International Alliance for Biological Standardization (IABS), Rue Mina-Audemars 3, 1204, Genève, Switzerland. Electronic address: joris.vandeputte@vaccim.eu.
Biologicals ; 85: 101723, 2024 Feb.
Article in En | MEDLINE | ID: mdl-37976940
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Limits: Humans Language: En Journal: Biologicals Journal subject: ALERGIA E IMUNOLOGIA Year: 2024 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Limits: Humans Language: En Journal: Biologicals Journal subject: ALERGIA E IMUNOLOGIA Year: 2024 Type: Article